2020.04.20. COVID-19 Virtual Meeting: April 20 - May 6, 2020
Join Innovimmune at the COVID-19 Virtual Partnering meeting. We are seeking out-licensing partners for the fast-tracked development of our proprietary INV-88 oral macrophage migration inhibitory factor inhibitors as a novel anti-cytokine-storm targeted therapy for ARDS in COVID-19. #PartneringAgainstCovid19 #INV-88 #COVID-19.